Canadian Generic Pharmaceutical Association (CGPA)
Registration:
3
of
11
(2020-10-22
to
2021-01-05)
Details Regarding the Identified Subject Matter
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Encouraging Support for the CGPA Blueprint for Sustainable Supply of Prescription Medicines for Canadians
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Policy and timing in respect of listing of sole-source and other generic drugs on the PharmaCare formulary where the price offered is higher than the Province's desired price. BC's position in respect of administration of pan-Canadian Pharmaceutical Association arrangements with the CGPA regarding generic drugs. Curtailing use of coupon cards for pharmaceutical products. Development of a regulatory pathway for biosimiars. Implementation of commitments made by British Columbia pursuant to its involvement with the pan-Canadian Pharmaceutical Alliance. Promoting greater utilization of generic prescription medicines. BC's position in respect of the National Pharmacare initiative. Accelerating time for listing of generic drugs after submission.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Signing Authority for Ministerial Orders to list generic products on the PharmaCare formulary
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
|
Health
|